SamaCare, a workflow platform for suppliers providing specialty remedy, introduced it secured $17 million in an oversubscribed Collection B funding spherical.
New investor Questa Capital led the spherical, with participation from present buyers South Park Commons and Vive Collective.
WHAT IT DOES
The California-based firm supplies a cloud-based workflow automation platform to assist suppliers acquire prior authorization for specialty drug medicines, test enrollment, and confirm advantages. It additionally works with pharmaceutical corporations to offer knowledge analytics to assist enhance entry to their therapies.
The corporate will use the funds to broaden its Script-to-Remedy Working System, which can leverage AI for administrative duties, create a post-prescription workflow, acquire knowledge insights and improve collaboration between suppliers’ workplaces.
“SamaCare plans to take a position the funds to construct the great Script-to-Remedy Working System, enhancing our specialty prior auth platform’s capabilities for sufferers, suppliers, and pharmaceutical corporations,” Syam Palakurthy, founder and CEO of SamaCare, advised MobiHealthNews in an electronic mail.
“This implies constructing into our platform extra collaboration options, AI-based steerage, and knowledge insights that collectively allow our prospects to make sure that sufferers overcome administrative and monetary obstacles to begin on therapy.”
MARKET SNAPSHOT
SamaCare closed a $12 million Collection A spherical in 2022.
Different corporations providing workflow automation platforms embrace Cerner, which was acquired by enterprise software program large Oracle in 2021 for $28.3 billion, and Epic, which affords medical and administrative workflow instruments.